Together, available data clearly demonstrate that AngII/AT1R signaling stimulates the expression of different cytokines and growth factors from tumor and stromal cells, which enhance cancer-related inflammation and promote an immuno-suppressive microenvironment (Fig. 2). Here, AGTR1 is linked to neoplasm.